ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 172 filers reported holding ANTARES PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,820,000 | -16.5% | 500,000 | 0.0% | 3.59% | -17.3% |
| Q2 2021 | $2,180,000 | +6.1% | 500,000 | 0.0% | 4.34% | -5.1% |
| Q1 2021 | $2,055,000 | +3.0% | 500,000 | 0.0% | 4.58% | -31.9% |
| Q4 2020 | $1,995,000 | +47.8% | 500,000 | 0.0% | 6.72% | +51.1% |
| Q3 2020 | $1,350,000 | -1.8% | 500,000 | 0.0% | 4.45% | +26.7% |
| Q2 2020 | $1,375,000 | +16.5% | 500,000 | 0.0% | 3.51% | +76.9% |
| Q1 2020 | $1,180,000 | -16.3% | 500,000 | +66.7% | 1.98% | -52.2% |
| Q4 2019 | $1,410,000 | +5.4% | 300,000 | -25.0% | 4.15% | +71.8% |
| Q3 2019 | $1,338,000 | +103.3% | 400,000 | +100.0% | 2.42% | +95.8% |
| Q2 2019 | $658,000 | -13.2% | 200,000 | -20.0% | 1.23% | -57.7% |
| Q1 2019 | $758,000 | +11.5% | 250,000 | 0.0% | 2.92% | +10.5% |
| Q4 2018 | $680,000 | -19.0% | 250,000 | 0.0% | 2.64% | +30.1% |
| Q3 2018 | $840,000 | +62.8% | 250,000 | +25.0% | 2.03% | +38.9% |
| Q2 2018 | $516,000 | – | 200,000 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |